Correlation Between DiaMedica Therapeutics and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and ProMIS Neurosciences, you can compare the effects of market volatilities on DiaMedica Therapeutics and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and ProMIS Neurosciences.
Diversification Opportunities for DiaMedica Therapeutics and ProMIS Neurosciences
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and ProMIS is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and ProMIS Neurosciences
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.66 times more return on investment than ProMIS Neurosciences. However, DiaMedica Therapeutics is 1.5 times less risky than ProMIS Neurosciences. It trades about 0.2 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.08 per unit of risk. If you would invest 430.00 in DiaMedica Therapeutics on August 29, 2024 and sell it today you would earn a total of 78.00 from holding DiaMedica Therapeutics or generate 18.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. ProMIS Neurosciences
Performance |
| Timeline |
| DiaMedica Therapeutics |
| ProMIS Neurosciences |
DiaMedica Therapeutics and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and ProMIS Neurosciences
The main advantage of trading using opposite DiaMedica Therapeutics and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |